About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half ...
Most adults (62%) say they have taken a GLP-1 drug to treat a chronic condition including diabetes or heart disease, while 43 ...
Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, ...
A NEW weight loss drug could hijack the brain like a ‘Trojan horse’ to double weight loss. The drug could help the body to ...
GLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access and pricing. CMS has taken steps ...
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill ...
Diabetes is a key risk factor for kidney disease, which is one of the leading causes of death in the United States and ...
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people taking GLP-1 drugs for weight loss.
It’s hard to watch TV these days without seeing an article or ad praising weight-loss wonder drugs. Some of these drugs, like ...
Drug Stocks latest news, photos, videos, breaking news, special reports, blogs, and updates from Business Insider India ...
(MENAFN- The Conversation) Obesity levels for adults have hit 26% in Britain and 42.5% in the United States, journalist Johann Hari writes in his new book, Magic Pill . In Australia, recent data shows ...
Wegovy, Ozempic and now retatrutide – the ‘miracle’ drugs are booming, but are they safe and how do they stack up?